Dynamic pathway regulation has emerged as a promising strategy in metabolic engineering for improved system productivity and yield, and continues to grow in sophistication. Bacterial stress-response promoters allow dynamic gene regulation using the host's natural transcriptional networks, but lack the flexibility to control the expression timing and overall magnitude of pathway genes. Here, we report a strategy that uses RNA transcriptional regulators to introduce another layer of control over the output of natural stress-response promoters. This new class of gene expression cassette, called a riboregulated switchable feedback promoter (rSFP), can be modularly activated using a variety of mechanisms, from manual induction to quorum sensing. We develop and apply rSFPs to regulate a toxic cytochrome P450 enzyme in the context of a Taxol precursor biosynthesis pathway and show this leads to 2.4x fold higher titers than from the best reported strain. We envision that rSFPs will become a valuable tool for flexible and dynamic control of gene expression in metabolic engineering, protein and biologic production, and many other applications.
Introduction
Sustainable production of chemicals and materials in microbes through metabolic engineering 1,2 is a long-standing focus of synthetic biology. A primary challenge in metabolic engineering is the burden and toxicity on engineered cells owing to heterologous enzyme expression and unnecessary intracellular accumulation of toxic pathway intermediates 3, 4 . This deleterious effect to the host often results in a loss to productivity and yield, creating a pressing need for strategies that can alleviate or avoid these pitfalls. This is nontrivial because each pathway can present unique cellular stresses, making it difficult to find generalizable solutions.
Synthetic biologists have sought to alleviate pathway toxicity by using dynamic pathway regulation to precisely tune the level and timing of enzyme expression [5] [6] [7] [8] . These systems are designed to adaptively adjust enzyme expression in response to changes in growth phase, cellular stress, fermentation conditions, and pathway intermediate concentrations so that they maintain an optimal concentration of enzymes that can vary over time. In order to implement these designs, synthetic biologists have created synthetic feedback networks that dynamically control gene expression using regulatory parts, such as engineered transcription factors [9] [10] [11] or ligand-induced ribozymes 12 , that respond to relevant cues.
While these systems represent important advances, synthetic feedback networks are often difficult to construct because the sensors required for specific inputs are hard to design or source from nature, and the added burden of expressing regulatory components can itself negatively impact the host 13 . Ultimately, this means that synthetic feedback networks require considerable additional engineering to match the specific requirements of every application. On the other hand, nature has evolved stress-responsive feedback networks that are already compatible with host cells. This is a result of the fact that microbial cells persist and thrive in changing environments due to their ability to sense and respond to stresses and environmental conditions 14 . Much of this ability is encoded within regulatory elements called stress-response promoters that integrate signals from complex and interconnected transcriptional networks to modulate mRNA synthesis in response to specific cellular stresses 15 . This creates the possibility of using stressresponse promoters to regulate heterologous pathway expression as a means to implement genetic feedback networks that lead to improvements in productivity and yield.
In fact, synthetic biologists have used stress-response promoters to control pathway expression, leading to notable improvements to productivity and yield for protein expression 16 and industrially important pathways, such as the artemisinin precursor amorphadiene 17 and n-butanol 18 . However, stress-response promoters have not been widely adopted, as their complexity makes it difficult to fine-tune their behavior for specific applications. As their function is determined by the complex topologies of natural genetic networks, there are no simple methods to tune either the timing or overall magnitude of their transcriptional outputs -two key parameters that are important for optimizing metabolic pathway productivity and yield 19 .
To address this limitation, we sought to create a new regulatory motif called a switchable feedback promoter (SFP) that combines the feedback properties of natural stress-response promoters with regulators that offer control of the timing and overall magnitude of transcriptional outputs ( Figure 1A -C). The SFP concept is general, and can be implemented in several ways including engineering transcription factor operator sites within the stress-response promoter region 20 . However, the architecture of many stressresponse promoters is still unknown, making the rational design of transcription factorbased SFPs difficult. Instead, we utilized trans-acting synthetic RNA regulators 21, 22 , which can be configured to control transcription in the case of small transcription activating RNAs (STARs) 21 , or translation in the case of toehold switches 22 . The key feature of both STARs and toehold switches is that they have well-defined composition rules such that they can be inserted into a gene expression construct without modification or disruption of the desired promoter sequence. In this way, riboregulated SFPs (rSFPs) can be created by inserting a STAR or toehold target binding region 3' of a natural stressresponse promoter (Fig. 1B) . By default, when transcribed, these RNA sequences fold into structures that block gene expression. However, binding of the trans-acting STAR or toehold trigger RNA changes these structures to allow gene expression. This enables the timing and overall magnitude of the rSFP output to be controlled with any strategy that can regulate the expression of the trans-acting RNA (Fig. 1C) . These regulators have additional advantages that make inclusion in rSFPs promising, including the availability of large libraries of orthogonal STARs and toehold switches with a range of functional properties (ON/OFF levels) 22, 23 and their having compact DNA footprints (<100nts).
Furthermore, they have been shown to control gene expression in a variety of contexts, including within metabolic pathways 23 .
Here we report the creation and characterization of a library of STAR-mediated rSFPs, and their application to optimizing the yield of a metabolic pathway that produces an oxygenated taxane precursor to the anticancer drug Taxol. We first show that we can create a library of 17 rSFPs by interfacing STARs with natural Escherichia coli stressresponse promoters and placing trans-acting STAR production under control of an inducible promoter. We then applied rSFPs to control the expression of a plant cytochrome P450 that is known to cause envelope stress 24 in the context of a pathway that produces an oxygenated Taxol precursor 25 . By screening rSFPs for oxygenated taxane production, we were able to find multiple rSFPs that showed improvement in both overall and oxygenated taxane titers compared to the previously reported best strain. We next used the external control of rSFPs to systematically optimize both timing and expression level to ultimately find pathway conditions that produce 25.4 mg/L of oxygenated taxanes and 39.0 mg/L of total taxanes, representing a 2.4x and a 3.6x fold improvement over the current state-of-the-art, respectively. To demonstrate the use of other control points for rSFPs, we next sought to interface them with a quorum sensing system and show that quorum sensing rSFPs offer completely autonomous pathway expression regulation with yields similar to our fully optimized system without costly external inducers.
Overall, rSFPs are a novel and general strategy to achieve dynamic regulation of metabolic pathway enzymes and we envision them to be broadly useful for introducing controllable stress-response promoters in many synthetic biology applications.
Results

Riboregulated switchable feedback promoters (rSFPs) enable tunable outputs from stress-response promoters
We chose to build rSFPs with STARs because they exhibit low leak and high dynamic range comparable to exemplary protein-based regulators 23 . STARs activate transcription by disrupting the folding pathway of a terminator hairpin sequence, called a Target, that is placed upstream of the gene to be regulated (Fig. 1B) . In the absence of a STAR, the Target region folds into an intrinsic terminator hairpin which stops transcription before reaching the downstream gene. When present, a STAR RNA can bind to the 5' portion of the terminator hairpin, preventing its formation, and allowing transcription. Our initial rSFP designs utilized a previously developed STAR 23 under the wellcharacterized inducible system TetR/PL,TetO1 20 interfaced with a library of 17 putative membrane stress-responsive promoters 17, 18 . These promoters were chosen as several had been previously identified to regulate a biofuel transporter protein in E. coli 18 , and could be valuable for dynamic regulation of membrane proteins in metabolic pathways.
To construct and characterize these rSFPs, a STAR Target sequence was cloned immediately 3' of each promoter to regulate expression of an mCherry reporter, and its cognate STAR was cloned in a second PL,TetO1 plasmid. Plasmids were transformed into E. coli and fluorescence was measured with and without the presence of the PL,TetO1 inducer anhydrotetracycline (aTc) at saturating levels (100 ng/mL). We found that induction of PL,TetO1-STAR resulted in significant activation from all members of the stressresponse promoter library ( Fig. 1D ), exemplifying the modularity of the rSFP concept. We also observed that 8 library members were activated by greater than 25x fold in the presence of aTc, with a maximum activation of nearly 150x fold (SI Fig. 1 ). We next selected a set of high-performing rSFPs and characterized their transfer functions by titrating levels of aTc and found that all exhibited a similar transfer function shape, though with different maximal activation levels ( 
rSFPs enhance production of an oxygenated Taxol precursor
We next tested the ability of rSFPs to regulate expression of a challenging metabolic pathway enzyme. As a model system, we chose a portion of the anticancer drug Paclitaxel's biosynthesis pathway that has been previously reconstituted in E. coli 24 .
Specifically, we focused on the first P450-mediated step where taxadiene is oxygenated by the membrane anchored cytochrome P450 CYP725A4 ( Fig. 2A) . This system is an ideal test bed for the use of rSFPs because CYP725A4 expression causes membrane stress due to lipid anchoring of an N-terminal domain. This stress appears to reduce pathway productivity and makes pathway optimizations extremely difficult 24 . The sensitivity of product titers to expression level of CYP725A4 must be carefully managed, as too low expression will create a bottleneck in oxygenated taxane synthesis, but too high expression will also suppress synthesis due to stress. Previous reports to optimize this system required significant experimental effort 24 , exemplifying the importance of new pathway engineering strategies, but also providing a competitive benchmark for comparison with rSFPs. Furthermore, this problematic expression is not unique to CYP725A4, but extends to many P450's 26, 27 , along with other classes of proteins such as transporters 18 and glycosylation enzymes 28, 29 . Therefore, the system is a model challenge for testing the concept of using rSFPs to leverage external control of natural stressresponse promoters to maintain pathway expression in a narrow optimal range.
Previous work has shown that expression level of a CYP725A4/tcCPR reductase fusion is critical to achieving high titers of oxygenated taxanes in E. coli 24 . A previously optimized low-copy expression vector (p5Trc-CYP725A4/tcCPR) (Fig. 2B) transformed into the E. coli Tax1 strain containing genomic modifications to maximize the synthesis of the taxadiene precursor, produces ~11 mg/L of oxygenated taxanes, albeit with a loss to total taxane production. However, increasing expression of the enzyme using a medium copy expression vector (p10Trc) does not increase titer, but causes a complete loss of pathway productivity (Fig. 2C) , presumably due to the enzyme's membrane stress crossing a critical threshold and triggering a global response. taxa-4 (5),11 (12)-diene (taxadiene). Taxadiene is oxygenated by the membraneanchored CYP725A4 fused with its reductase partner (tcCPR) to form taxadiene-5a-ol. rSFPs utilizing envelope stress-response promoters are applied to control the expression of CYP725A4/tcCPR. IPP = isopentenyl diphosphate, DMAP = dimethylallyl diphosphate. (b) Plasmids used for CYP725A4/tcCPR expression in E. coli Tax1. CYP725A4/tcCPR is expressed from a standard IPTG-inducible PTrc promoter in either a low copy (p5Trc, SC101) or medium copy (p10Trc, pACYC) plasmid, or from rSFPs with various Pstress promoters encoded on a p15a plasmid. PL,TetO1-STAR was used to activate rSFP expression. rSFPs allow CYP725A4/tcCPR expression to be controlled by externally supplied aTc and feedback-regulated by the natural stress response pathways. p5Trc is a gold standard CYP725A4/tcCPR expression system from previously reported optimization efforts. (c) Titers of fermentations with empty E. coli Tax1 and E. coli Tax1 containing low copy p5Trc or medium copy p10Trc expression of CYP725A4/tcCPR. Addition of p5Trc to E. coli Tax1 enables production of oxygenated taxanes at a cost to overall taxane production, while addition of p10Trc eliminates nearly all taxane production presumably due to the toxicity of CYP725A4/tcCPR expression. We hypothesized we could achieve greater pathway productivity over the p5Trc benchmark strain by identifying putative envelope stress rSFPs for control of CYP725A4/tcCPR. To test this, the CYP725A4/tcCPR coding sequence was introduced into each one of the 17 rSFP constructs. E. coli Tax1 was transformed with each rSFP construct and the PL,TetO1-STAR plasmid and each tested in the context of taxadiene oxygenation fermentations with addition of 100 ng/mL aTc at inoculation. Using this approach, we found that several performed well against the p5Trc benchmark strain (SI Fig. 2 ). In particular, 7 of the rSFPs had greater titers of oxygenated taxanes than the p5Trc strain (Fig. 2D) , with all also improving overall taxane production. Furthermore, the PompF rSFP resulted in ~2.2x fold greater oxygenated taxanes (~23.5 mg/L) and ~2.8x fold greater overall taxanes (29.8 mg/L) than the p5Trc strain, clearly showing the benefit of rSFP pathway regulation.
To confirm that rSFPs can indeed be feedback regulated by CYP725A4/tcCPR stress, we performed fluorescence analysis of E. coli cells containing plasmids for rSFP expression of an mCherry reporter with the top two performing stress-response promoters and the p10Trc plasmid separately expressing CYP725A4/tcCPR, in order to monitor changes in rSFP expression caused by membrane stress (SI Fig. 3A) . We observed reduced expression from PompF when p10Trc was present in place of an empty vector (SI Fig. 3B ), suggesting that it is indeed responsive to CYP725A4/tcCPR induced stress. On the other hand, a constitutive promoter control had no response as expected.
Interestingly, the PmetN rSFP did not exhibit a reduced expression in response to CYP725A4/tcCPR expression, indicating that not all rSFPs respond to stresses in the same way, as we expected for a diverse set of natural stress-response promoters.
Overall these results show that rSFPs can be effectively used to optimize overall pathway expression and that they can exhibit the dynamic feedback behaviors of incorporated stress-response promoters.
rSFPs allow further pathway optimization through the control of expression timing and overall magnitude
Having shown significant improvements in taxadiene oxygenation with rSFPs, we next sought to test how the external control offered by rSFPs can be used to further optimize induction level and timing of stress-response promoter activity. To test this, we selected the two best rSFP systems and performed a matrix of aTc induction at four levels (0, 16, 32, and 100 ng/mL aTc), which were added at six different induction times (0, 3, 6, 12, 24, 48 hrs) post fermentation inoculation (Fig. 3A-B) . We found that oxygenated taxane production with both rSFPs was indeed sensitive to induction level and timing ( (Fig. 3E,F) , representing an overall 2.4x and 2.3x fold improvement over the previous gold standard benchmark in terms of oxygenated taxanes, and 3.6x and 2.9x fold improvements in terms of overall taxanes. These results demonstrate that rSFPs can be implemented to enable rapid tuning of expression timing and overall magnitude of stress-response promoter output to further enhance fermentation titers. (e, f) Titers of fermentations with E. coli Tax1 containing the PmetN (e) or PompF (f) rSFP before (100 ng/mL aTc at 0 hrs) and after induction optimization. Dashed line represents production of oxygenated taxanes from p5Trc. Data in c, d, e, f represent mean values of fermentation titers after 96 hrs and error bars represent s.d. of at least n = 3 biological replicates. * indicate a statistically significant difference in oxygenated taxane production by a two-tailed Welch's t-test (* = P < 0.05, ** = P < 0.005).
Quorum-sensing activated rSFPs allow autonomous regulation of pathway expression
Though inducible systems offer flexibility for screening of optimal induction timing, the cost of inducers can be prohibitive at an industrial scale 30, 31 , and several efforts have been carried out to design autonomous means of induction. Quorum-sensing (QS) systems that are activated in a cell-density dependent manner offer one such route to this behavior 32 . QS systems have been used with great utility in metabolic engineering to create a separation of cell growth and pathway production phases without the need for a chemical inducer, and provide a natural means for balancing carbon utilization with biomass production [33] [34] [35] . We therefore sought to utilize this strategy within our model pathway by leveraging the modularity of rSFPs to be easily configured to utilize different input systems. Specifically, we chose the PLux promoter that is activated by the LuxR transcriptional activator upon sufficient production of the C6-homoserine lactone (HSL) signaling molecule 36 . We cloned a STAR under control of PLux and integrated an operon with the EsaI HSL synthase 37 and LuxR into the genome of the E. coli Tax1 strain to create the Tax1-QS strain (Fig. 4A) . When plasmids encoding the expression of PLux-STAR and the PmetN or PompF rSFPs controlling mCherry expression were transformed into E. coli Tax1 or Tax1-QS, we found that activation only occurred in the engineered Tax1-QS strain containing EsaI and LuxR (Fig. 4B) . These QS-activated rSFPs produced comparable fold activation to manual induction with PL,TetO1 and exhibited a time dependent activation. To demonstrate that QS-activated rSFPs could be used to autonomously control the expression of metabolic pathway enzymes, we applied the PmetN and PompF QSactivated rSFPs to control the expression of CYP725A4/tcCPR within the taxadiene oxygenation pathway. Fermentations were performed by inoculating cell cultures into media without addition of exogenous inducer. Upon fermentation and analysis, we found that QS-based activation resulted in comparable titers of oxygenated taxanes to those obtained from manual induction of rSFPs with aTc before optimization (Fig. 4C,D) .
Importantly, this represented 1.7x and 2x fold improvements, respectively, over the previous gold standard, and was achieved with a completely autonomous genetic feedback network without the need for costly inducers.
Discussion
Here we report the development, characterization and application of switchable feedback promoters that enable an additional synthetic layer of control over natural stress-response promoters. Stress-response promoters are a promising route to achieving dynamic control of heterologous metabolic pathways by acting as sensor-actuators to stresses caused by pathway expression, intermediate metabolites and other fermentation conditions 17, 18 . While stress-response promoters can improve production of desired chemicals by regulating expression in response to toxic pathway intermediates and enzymes, they are constrained by their complexity, leading to a lack of control over the timing and overall magnitude of their transcriptional output, which is essential to achieving a separation of growth phase and production phase in large-scale fermentations 38 . By design, the rSFP concept enables this control by introducing an additional regulatory layer within the natural stress-response pathway by gating stressresponse promoter outputs with trans-acting RNA regulators. The use of an inducible promoter to control RNA regulator synthesis allows modification of the timing and overall magnitude of the natural stress-response promoter outputs. Furthermore, the use of QS systems allows the autonomous activation of rSFPs in a cell-density dependent manner.
In this way, rSFPs have modularity both at the lever of their inputs and outputs, and the types of stresses they can respond to through changing of the regulated stress-response promoter. This offers the flexible implementation of controllable stress-response networks in a single compact locus.
In this work, we design and implement rSFPs and demonstrate that they are both modular and tunable -the rSFP concept can be applied to many unique stress-response promoters in a plug-and-play fashion, activator inputs can be easily interchanged, and activated output levels can be modulated by titrating inducer concentrations. Notably, we found that all 17 of the stress-response promoters that were inserted into rSFPs were activated significantly, strongly suggesting that rSFPs can be used with new stressresponse promoters as they are discovered, and potentially that the rSFP concept can be used to easily regulate engineered promoter systems as well. These features allow rapid screening of rSFP libraries within combinatorial strain engineering procedures 39 that could be used by industry to identify effective implementations of dynamic control. In addition, the ability of rSFPs to naturally adapt to an optimal expression level may allow for rapid prototyping of potentially toxic enzymes and pathways without the requisite need to first balance expression levels with constitutive static regulators -speeding the pace of pathway construction for new chemical products.
To demonstrate their utility in the context of optimizing metabolic pathway production, we applied rSFPs to a synthetic Taxol precursor pathway in E. coli 25 by regulating expression of a problematic cytochrome P450 enzyme that causes a membrane stress detrimental to productivity 24 . By screening through a library of envelopestress-response promoters in rSFPs, we identified variants that improved pathway productivity over a previous strain that had been optimized using a laborious trial-anderror approach. Furthermore, we showed that optimizing rSFP induction timing and magnitude in the fermentation enabled additional improvements, highlighting an advantage of the rSFP system to enable the control of pathway expression timing. We also showed that rSFPs can be controlled by QS systems that do not require addition of an external inducer, enabling fully autonomous control of pathway expression.
Dynamic pathway regulation is a promising strategy in metabolic engineering but can be difficult to implement. The rSFP strategy enables modular and tunable control of endogenous promoters that have evolved sophisticated transcriptional responses to a range of cellular stresses and fermentation conditions. Due to their simplicity, we envision that the rSFP concept will enable streamlined implementation of dynamic regulation into metabolic pathways. Furthermore, given their modularity, we imagine rSFPs will be useful for dynamic control in other applications, such as high-level expression of difficult or toxic proteins, living therapeutics 40 , and cellular diagnostics 41 where endogenous promoters could be used as sensor-actuators for numerous environments.
Methods
Plasmid assembly. All plasmids used in this study can be found in Supplementary Table 1 with key sequences provided in Supplementary Tables 2 and   3 . Gibson assembly and inverse PCR (iPCR) was used for construction of all plasmids.
All assembled plasmids were verified using DNA sequencing.
Integration of QS operon into the E. coli genome. Strains containing genomic insertions of the EsaI-LuxR operon were created using the clonetegration 42 platform as summarized in Supplementary Table 4 . The HK022 plasmid was used to integrate constructs into the attB site of the E. coli genome. Successful integrations were identified by antibiotic selection and colony PCR according to the published protocol.
Strains, growth media, in vivo bulk fluorescence measurements.
Fluorescence characterization experiments for all envelope stress-response promoters were performed in E. coli strain Tax1 24 containing the synthetic pathway for taxadiene biosynthesis or modified Tax1-QS containing the QS operon. Experiments were performed for 7-9 biological replicates collected over three separate days. For each day of fluorescence measurements, plasmid combinations were transformed into chemically competent E. coli cells and plated on LB+Agar (Difco) plates containing combinations of 100 μg/mL carbenicillin, 34 μg/mL chloramphenicol and/or 50 μg/mL spectinomycin depending on plasmids used (see SI Table 1 Occasional wells were discarded due to poor growth (OD < 0.1 at measurement), however, all samples contained at least 7 replicates over the three experiments. Means of FL/OD were calculated over replicates and error bars represent standard deviations (s.d).
Small-scale "Hungate" fermentation. Small-scale fermentation assays were used to quantify oxygenated taxanes and taxadiene production in E. coli Tax1 or Tax1-QS. Experiments were performed with six biological replicates collected over three independent experiments (Figure 2c, 2d) or four biological replicates collected over two independent experiments (Figure 3c, 3d, 3e, 3f, 4c, 4d) . For each experiment, plasmid combinations (SI Table 1 ) were transformed into chemically competent E. coli cells and plated on LB+Agar (Difco) plates containing appropriate antibiotics (100 μg/mL carbenicillin, 34 μg/mL chloramphenicol and/or 50 μg/mL spectinomycin). Plates were incubated approximately 17 hrs overnight at 30 °C. Individual colonies were inoculated into culture tubes containing LB and appropriate antibiotics and incubated at 30°C for roughly 16 hrs overnight to achieve an approximate OD600 of 3. For 2 mL batch fermentations, 50 µL of overnight cells were added to 1.95 mL of complete R-media (Supplementary Tables 5-7 ) and appropriate antibiotics in glass hungate tubes (ChemGlass). 0.1 mM IPTG was added for induction of the upstream pathway enzymes and p5Trc/p10Trc expression. 16-100 ng/mL aTc was added, as indicated, to induce PL,TetO1-STAR activated rSFPs. A 10% v/v dodecane layer (200 µL) was added in all fermentations. Hungate tubes were sealed with a rubber septa and plastic screw-cap (ChemGlass). PrecisionGlide 18G hypodermic needles (BD) were inserted into the rubber septa to allow for gas exchange. Hungate tubes were incubated at 22°C and 250 rpm for 96 hrs. After the fermentations were completed, the culture was centrifuged to collect the dodecane overlay. This overlay was subsequently diluted into hexane for analytical procedures described below. 
